Association of Pharmacy
Technicians UK (APTUK)
The Professional Leadership Body for Pharmacy Technicians

New research suggests that penicillin allergy increases the risk of infections with methicillin resistant Staphylococcus aureus (MRSA) and Clostridium difficile.

Researchers used data from UK general practice to match 64,141 adults with penicillin allergy to 237,258 controls. During a mean follow-up of approximately six years, 442 people with penicillin allergy and 923 controls developed MRSA, while 442 and 1,246 respectively developed C. difficile.

Patients with penicillin allergy were 70 per cent less likely to be prescribed penicillin than controls but were about four times more likely to receive macrolides (incidence rate ratio [IRR] 4.15) or clindamycin (IRR 3.89), twice as likely to receive fluoroquinolones (IRR 2.10) or tetracyclines (IRR 1.75) and 26 per cent more likely to receive sulphonamides.

After adjusting for confounders, patients with penicillin allergy were 69 per cent more likely to develop MRSA and 26 per cent more likely to develop C. difficile. Increased use of antibiotics that are alternatives to betalactams accounted for 55 and 35 per cent of the increased risk of MRSA and C. difficile respectively.

Previous studies have reported that 95 per cent of patients who reported penicillin allergy were tolerant to the antibiotic, while 80 per cent of patients who show an immediate hypersensitivity reaction to penicillin are no longer allergic 10 years later.

“As infections with resistant organisms increase, systematic efforts to confirm or rule out the presence of true penicillin allergy may be an important public health strategy to reduce the incidence of MRSA and C. difficile,” the authors conclude.

(BMJ 2018; 361:k2400)

Originally Published by Pharmacy Magazine

Related articles

Conference call: ASHP updates on opioid crisis

Opioid over-prescribing, medical cannabis and digital health developments were some of the topics covered

Time for action on obesity

The UK population is more obese and less active than ever before. Can pharmacists help turn things around?

Wound & scar management: Could do better

Dermatologists want community pharmacists and other healthcare professionals to provide better advice

More articles

Chief Pharmaceutical Officer's Conference

Chief Pharmaceutical Officer's Conference 1st May - Book your place now!

Managing hay fever: meet your customers’ needs

This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the r...

The start of a journey

In her first column as APTUK president, Liz Fidler makes her introductions and discusses her vision for APTUK and her co...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Association of Pharmacy Technicians UK (APTUK)'s Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.